Therapeutic Solutions Receives Allowance on Patent Claim from the US Patent Office Covering ProJuvenol(R) Active Ingredient Pterostilbene in Cancer Immunotherapies
EIN Newsdesk,
/ EINPresswire.com / -- OCEANSIDE, CA --(Marketwired - February 06, 2017) - Therapeutics Solutions International, Inc., (OTC…